Jim DeMesa, MD, MBA

Jim DeMesa, MD, MBA, is CEO of Emerald Health Pharmaceuticals (a subsidiary of Emerald Health Sciences Inc., the Company’s largest shareholder) with 28-years’ experience in pharmaceutical product development, co-founder of MedXcel, a medical education company, member of the Boards of Directors of OncoSec Medical and Induce Biologics, and a former practicing physician.